Skip to main content
HighlightsHighlights Archive

Media Monitoring: 18 – 24 April

By April 23, 2024No Comments

Women’s health hubs

  • The recently published 2024/25 operational planning guidance asks ICBs to “establish and develop at least one women’s health hub in every ICB by the end of December 2024 in line with the core specification.
  • It sets the expectation that at least 75% of ICBs have a hub in place by July 2024 that meets minimum requirements.
  • The expansion of women’s health hubs is a key priority and NHSE are investing £25 million in women’s health hubs over 2023/24 and 2024/25, with £595,000 in total for each ICB.


Innovate UK and British Business Bank sign MoU

  • Innovate UK and the British Business Bank have further strengthened their collaboration by signing a memorandum of understanding (MoU).
  • As partners dedicated to fostering innovation and growth of UK businesses across the country, this new collaboration will see the two organisations working even more closely.
  • Together they will co-create new opportunities to promote investment and to support UK businesses through better tailored offerings.


Tackling medical attrition in the UK’s health services – a BMA report

  • The report states that too many doctors are pushed to leave the workforce early, from early career to before retirement age. For every doctor that leaves, pressures worsen for those who stay, increasing the likelihood that they too will leave the profession.
  • Between September 2022 and September 2023, 15,000 – 23,000 doctors left the NHS prematurely in England alone to the cost of between £1.6 and £2.4 billion.
  • The cost of attrition is high, but properly valuing doctors and their contribution provides an attainable solution to the problem. The BMA recommends action in four key areas: (1) pay and debt, (2) working conditions, (3) diversity and inclusion and (4) development and support.


Search for new type 1 diabetes treatments aided by siblings with genetic change

  • Two siblings who have the only known mutations in a key gene have helped scientists find potential type 1 diabetes treatments.
  • The new research, published in the Journal of Experimental Medicine, began when researchers studied two siblings who were diagnosed with a rare genetic form of autoimmune diabetes in the first weeks of life.
  • The University of Exeter offers free genetic testing worldwide for babies diagnosed with diabetes before they are nine months old.


St George’s, University of London partners with Tachmed to accelerate new at-home digital diagnostics

  • Leading specialists in infection diagnostics at St George’s, University of London have partnered with Tachmed to accelerate the development of its first in market, affordable diagnostics that are connected digitally for use in the home.
  • The partnership will lead to the creation of diagnostic tests that remove the need for patient interpretation of results and can be done in the comfort of their home.
  • During the four-month collaboration, which is funded by an Innovate UK Accelerated Knowledge Transfer grant, Dr Henry Staines from St George’s will provide ‘critical’ knowledge exchange to boost the development of the technology by optimising Tachmed’s biosensor that is required to confirm if a pathogen is present or not within a patient sample.


CARB-X funds Scout to develop a low-cost point-of-care diagnostic for STI testing

  • Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to 1 million USD to diagnostics and health tech company Scout to demonstrate proof-of-concept and feasibility ahead of development of a new point-of-care test, STI Scout.
  • The test will detect and differentiate between Neisseria gonorrhoeae (Ng) and Chlamydia trachomatis (Ct). STI Scout is quick and inexpensive according to CARB-X, with a turnaround time of 30 minutes and costs anticipated to be less than half of other options.
  • Additionally, STI Scout can use either first void urine or vaginal swabs, and future tests will be able to guide therapy for gonorrhea treatment based on antibiotic susceptibility.


HIV and viral hepatitis diagnostic tests in low- and middle-income countries: forecasts of global and regional demand for 2022-2026

  • The purpose of this report is to provide forecasts of future demand for diagnostic tests used in the fields of HIV and viral hepatitis.
  • These forecasts have multiple potential uses. First, they may inform advocacy efforts to increase access to diagnostics. Second, they may guide health systems and procurement organizations in planning how to obtain adequate supplies of diagnostics to fulfil service delivery needs. Third, they may aid manufacturers in identifying opportunities to contribute to meeting anticipated market demands.


Decarbonisation and net zero: How the NHS can unlock its long-term sustainable future – report

  • This guide showcases the NHS’s efforts in tackling climate change, enhancing healthcare, and overcoming economic hurdles through innovation and strategic energy management.


China is a national security threat to UK health data, leaked letter reveals

  • The Government is moving to protect British DNA data from Chinese hacking attempts, amid warnings they pose a risk to national security, a leaked letter suggests.
  • The correspondence appeared to confirm the UK had concerns about the Chinese BGI Group, following accusations that it had launched multiple hack attempts against Genomics England that were previously officially retracted.
  • It comes after MPs raised concerns that Chinese hacking, including alleged attempts by BGI, would allow Beijing to analyse and predict which diseases may impact the British population.
Ben Kemp